These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24401847)

  • 1. Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.
    Stephens RS; Servinsky LE; Rentsendorj O; Kolb TM; Pfeifer A; Pearse DB
    Am J Physiol Cell Physiol; 2014 Mar; 306(6):C559-69. PubMed ID: 24401847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cGMP increases antioxidant function and attenuates oxidant cell death in mouse lung microvascular endothelial cells by a protein kinase G-dependent mechanism.
    Stephens RS; Rentsendorj O; Servinsky LE; Moldobaeva A; Damico R; Pearse DB
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L323-33. PubMed ID: 20453163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abl family kinases regulate endothelial barrier function in vitro and in mice.
    Chislock EM; Pendergast AM
    PLoS One; 2013; 8(12):e85231. PubMed ID: 24367707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.
    Letsiou E; Rizzo AN; Sammani S; Naureckas P; Jacobson JR; Garcia JG; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L259-69. PubMed ID: 25480336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells.
    Okabe S; Tauchi T; Katagiri S; Tanaka Y; Ohyashiki K
    J Hematol Oncol; 2014 Apr; 7():37. PubMed ID: 24775308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.
    Kim SY; Cordeiro MH; Serna VA; Ebbert K; Butler LM; Sinha S; Mills AA; Woodruff TK; Kurita T
    Cell Death Differ; 2013 Aug; 20(8):987-97. PubMed ID: 23598363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.
    Hinchcliff M; Huang CC; Ishida W; Fang F; Lee J; Jafari N; Wilkes M; Bhattacharyya S; Leof E; Varga J
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S86-96. PubMed ID: 22691216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
    Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
    Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
    Raimondi C; Fantin A; Lampropoulou A; Denti L; Chikh A; Ruhrberg C
    J Exp Med; 2014 Jun; 211(6):1167-83. PubMed ID: 24863063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.
    Bhattacharyya S; Ishida W; Wu M; Wilkes M; Mori Y; Hinchcliff M; Leof E; Varga J
    Oncogene; 2009 Mar; 28(10):1285-97. PubMed ID: 19151753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2.
    Xia CQ; Zhang P; Li S; Yuan L; Xia T; Xie C; Clare-Salzler MJ
    PLoS One; 2014; 9(5):e97694. PubMed ID: 24835010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.
    Lin J; Sun T; Ji L; Deng W; Roth J; Minna J; Arlinghaus R
    Oncogene; 2007 Oct; 26(49):6989-96. PubMed ID: 17486070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.
    Tseng PH; Lin HP; Zhu J; Chen KF; Hade EM; Young DC; Byrd JC; Grever M; Johnson K; Druker BJ; Chen CS
    Blood; 2005 May; 105(10):4021-7. PubMed ID: 15665113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic processing of cGMP-dependent protein kinase I mediates nuclear cGMP signaling in vascular smooth muscle cells.
    Sugiura T; Nakanishi H; Roberts JD
    Circ Res; 2008 Jul; 103(1):53-60. PubMed ID: 18535260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.
    Huang DY; Chao Y; Tai MH; Yu YH; Lin WW
    J Biomed Sci; 2012 Mar; 19(1):35. PubMed ID: 22462553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations.
    Seeliger MA; Ranjitkar P; Kasap C; Shan Y; Shaw DE; Shah NP; Kuriyan J; Maly DJ
    Cancer Res; 2009 Mar; 69(6):2384-92. PubMed ID: 19276351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.
    Guo Y; Shan Q; Gong Y; Lin J; Yang X; Zhou R
    Cancer Biol Ther; 2012 Nov; 13(13):1244-54. PubMed ID: 22895079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells.
    Sugimoto Y; Nakamura S; Okinaka K; Hirano I; Ono T; Shigeno K; Shinjo K; Ohnishi K
    Leuk Res; 2008 Jun; 32(6):962-71. PubMed ID: 18190961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate stimulates low-density lipoprotein receptor-related protein 1-mediated ERK phosphorylation in insulin-producing cells.
    Fred RG; Boddeti SK; Lundberg M; Welsh N
    Clin Sci (Lond); 2015 Jan; 128(1):17-28. PubMed ID: 24865476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.